KRTX - Karuna Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Karuna Therapeutics's activity chart (see below) currently has 169 price targets and 128 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 97.56% with an average time for these price targets to be met of 214.63 days.

Most recent stock forecast was given by from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 23-Jul-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 11-Mar-2024

$330

$-5200.92 (-94.03%)

$330

2 years 6 months 23 days ago
(11-Mar-2024)

15/15 (100%)

$10.81 (3.39%)

250

Hold Since 08-Mar-2023

$330

$-5200.92 (-94.03%)

$330

2 years 7 months 14 days ago
(20-Feb-2024)

4/4 (100%)

$11.41 (3.58%)

66

Buy Since 06-Feb-2020

$245

$-5285.92 (-95.57%)

$245

2 years 8 months 8 days ago
(26-Jan-2024)

13/14 (92.86%)

$-69 (-21.97%)

176

Buy Since 28-Apr-2020

$330

$-5200.92 (-94.03%)

$280

2 years 9 months 12 days ago
(22-Dec-2023)

6/6 (100%)

$12.15 (3.82%)

246

Buy Since 30-Aug-2021

$227

$-5303.92 (-95.90%)

$227

2 years 9 months 12 days ago
(22-Dec-2023)

5/6 (83.33%)

$-90.85 (-28.58%)

177

Show more analysts

Please expand the browser size to see the chart

What is KRTX (Karuna Therapeutics) average time for price targets to be met?

On average it took 215 days for the stock forecasts to be reached, with an average price target met ratio of 97.56%.

Which analyst most recently updated their price target on KRTX (Karuna Therapeutics)?

Which analyst has the most public recommendations on KRTX (Karuna Therapeutics)?

has 0 price targets and 0 ratings on KRTX

Which analyst is the currently most bullish on KRTX (Karuna Therapeutics)?

Myles Minter with the highest potential upside of $0

Which analyst is the currently most reserved on KRTX (Karuna Therapeutics)?

Liana Moussatos with the lowest potential downside of -$5396.92
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?